Orbimed Advisors - CHINOOK THERAPEUTICS INC ownership

CHINOOK THERAPEUTICS INC's ticker is KDNY and the CUSIP is 16961L106. A total of 103 filers reported holding CHINOOK THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.4%.

Quarter-by-quarter ownership
Orbimed Advisors ownership history of CHINOOK THERAPEUTICS INC
ValueSharesWeighting
Q1 2023$46,978,295
-11.6%
2,029,3000.0%0.92%
-9.3%
Q4 2022$53,167,660
+33.3%
2,029,3000.0%1.02%
+37.2%
Q3 2022$39,896,000
+20.3%
2,029,300
+7.0%
0.74%
+23.3%
Q2 2022$33,166,000
+42.9%
1,896,300
+33.7%
0.60%
+59.8%
Q1 2022$23,203,000
+0.3%
1,418,3000.0%0.38%
+26.6%
Q4 2021$23,132,000
+27.6%
1,418,300
-0.2%
0.30%
+49.2%
Q3 2021$18,127,000
-3.7%
1,420,637
+6.5%
0.20%
+4.7%
Q2 2021$18,833,000
-3.0%
1,333,801
+6.7%
0.19%
+4.4%
Q1 2021$19,425,000
-2.0%
1,250,0010.0%0.18%
+5.2%
Q4 2020$19,825,0001,250,0010.17%
Other shareholders
CHINOOK THERAPEUTICS INC shareholders Q4 2021
NameSharesValueWeighting ↓
Samsara BioCapital, LLC 5,161,888$135,241,46629.11%
Octagon Capital Advisors LP 2,551,703$66,854,61910.41%
Affinity Asset Advisors, LLC 818,035$21,432,5178.40%
Frazier Life Sciences Management, L.P. 4,345,559$113,853,6467.08%
Saturn V Capital Management LP 423,177$6,728,2985.58%
Altium Capital Management LP 385,000$10,087,0005.13%
Deep Track Capital, LP 3,000,000$78,600,0003.30%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 340,389$8,914,7882.75%
Vivo Capital, LLC 872,151$22,8502.63%
Nan Fung Group Holdings Ltd 113,950$2,985,4902.06%
View complete list of CHINOOK THERAPEUTICS INC shareholders